Industry criticizes India's reliance on drug importers for ADR-related action
This article was originally published in SRA
Executive Summary
India has underscored the significance of proactive reporting by drug importers of adverse reaction-related "administrative action" of foreign regulators as part of the country's efforts to improve regulatory compliance1.